This report studies the Active Pharmaceutical Ingredients market. An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug. Scope of the Report: This report focuses on the Active Pharmaceutical Ingredients in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications. Market Segment by Manufacturers, this report covers Teva Mylan DSM Aurobindo Pharma Aspen Novartis BASF Pfizer Huahai Pharmaceutical Hisun Pharmaceutical Sun Pharmaceutical Industries Zhejiang Medicine Dr. Reddy?s Laboratories Zhejiang NHU Bayer NCPC AbbVie Shandong Xinhua Pharmaceutical Northeast Pharm Harbin Pharmaceutical LKPC Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Synthetic APIs Biotech APIs Market Segment by Applications, can be divided into CNS Cardiovascular Genitourinary/Hormonal Drugs Respiratory Rheumatology Diabetes Oncology Others There are 15 Chapters to deeply display the global Active Pharmaceutical Ingredients market. Chapter 1, to describe Active Pharmaceutical Ingredients Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Active Pharmaceutical Ingredients, with sales, revenue, and price of Active Pharmaceutical Ingredients, in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Active Pharmaceutical Ingredients, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions; Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018; Chapter 12, Active Pharmaceutical Ingredients market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023; Chapter 13, 14 and 15, to describe Active Pharmaceutical Ingredients sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents 1 Market Overview 1.1 Active Pharmaceutical Ingredients Introduction 1.2 Market Analysis by Type 1.2.1 Synthetic APIs 1.2.2 Biotech APIs 1.3 Market Analysis by Applications 1.3.1 CNS 1.3.2 Cardiovascular 1.3.3 Genitourinary/Hormonal Drugs 1.3.4 Respiratory 1.3.5 Rheumatology 1.3.6 Diabetes
